#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17072	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2110	800.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1481	1481	C	972	C	894	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17072	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2110	800.9	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1709	1709	T	972	TGGGGG,TGGGGGG	460,381	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17072	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2110	800.9	0	HET	.	.	.	C1525T	.	1525	1525	C	1822	1822	C	837	C,T	400,365	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31162	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3572	865.8	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	1045	C	959	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31162	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3572	865.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1946	1946	G	1066	G,A	981,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31162	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3572	865.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	1044	C,T	948,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31162	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3572	865.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	996	A	927	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31162	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3572	865.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	971	C,T	900,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2378	folP	855	855	100.0	folP.l15.c4.ctg.1	1453	161.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1007	1009	AGC	233;235;235	A,G;G;C	218,1;221;220	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6382	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	185.9	1	SNP	p	S91F	1	.	.	271	273	TTC	661	663	TTC	216;217;218	T;T;C	210;211;210	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6382	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	185.9	1	SNP	p	G95N	0	.	.	283	285	GGC	673	675	GGC	214;215;217	G;G;C	201;203;202	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6382	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	185.9	1	SNP	p	D95G	1	.	.	283	285	GGC	673	675	GGC	214;215;217	G;G;C	201;203;202	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1818	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1178	152.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	827	829	TTG	215;214;216	T;T;G	200;199;200	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1818	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1178	152.9	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	224;224;225	G,T;G;C	203,1;199;204	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	884	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1096	80.3	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	216	A	207	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2902	207.2	1	SNP	p	D86N	0	.	.	256	258	GAC	520	522	GAC	259;255;256	G;A;C	244;233;240	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2902	207.2	1	SNP	p	R87W	0	.	.	259	261	CGT	523	525	CGT	255;256;259	C;G;T	237;236;237	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2902	207.2	1	SNP	p	R87I	0	.	.	259	261	CGT	523	525	CGT	255;256;259	C;G;T	237;236;237	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2902	207.2	1	SNP	p	S87R	1	.	.	259	261	CGT	523	525	CGT	255;256;259	C;G;T	237;236;237	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6078	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2902	207.2	1	SNP	p	S88P	0	.	.	262	264	TCC	526	528	TCC	258;258;260	T;C,A;C	239;237,1;242	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5130	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2521	200.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	222;218;217	G;G;C	211;207;205	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1101	1103	GCA	269;271;272	G;C;A	236;236;242	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1104	1106	ATC	276;278;281	A;T;C	243;245;250	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1116	1118	GTG	271;272;276	G;T;G	246;247;252	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1116	1118	GTG	271;272;276	G;T;G	246;247;252	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1620	1622	ACC	236;235;235	A;C;C	212;216;215	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1674	1676	GCG	226;224;224	G;C,G;G	191;173,1;187	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1674	1676	GCG	226;224;224	G;C,G;G	191;173,1;187	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1797	1799	AGC	220;219;219	A;G;C	202;204;201	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1806	1808	GGC	219;216;210	G;G;C	199;192;186	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4724	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2161	215.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1824	1826	CCG	188;196;195	C,G;C;G	132,5;142;141	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6468	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3116	205.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1585	1587	CCG	245;245;245	C;C;G	222;227;224	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2508	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1728	143.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	568	568	C	164	C	155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	T26A	NONSYN	76	78	ACC	389	391	GCC	272;269;269	G;C;C	254;251;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	425	427	GAA	272;271;266	G;A;A	246;247;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	740	742	CAA	231;230;233	C;A;A	215;215;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	836	838	TCA	226;226;227	T;C;A	202;204;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	N213D	NONSYN	637	639	AAT	950	952	GAT	202;204;203	G,A;A;T	192,1;196;193	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	F215T	NONSYN	643	645	TTT	956	958	ACT	202;201;202	A;C;T	195;197;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	A218M	NONSYN	652	654	GCC	965	967	ATG	213;216;216	A;T;G,C	203;208;205,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1187	1189	ACT	246;243;245	A,T;C;T	218,1;224;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1193	1195	GAT	241;239;238	G,C;A;T	219,1;216;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1202	1204	AAC	230;231;232	A,G;A;C	210,1;209;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	97.52	porB1b.l6.c4.ctg.1	1671	172.2	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1205	1207	CAC	233;236;234	C,T;A;C	212,1;213;216	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11634	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4736	243.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1246	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1082	114.7	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	256;254;250	A;T;G	244;242;239	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
